pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia
Objective: To analyze the behavior of pH and sodium bicarbonate (NAHCO3) in the saliva of patients with leukemia during the administration protocol for Methotrexate (Mtx). Materials and Methods: A controlled clinical essay was carried out on 23 patients between 4 and 18 years of age with high-risk Acute Lymphoblastic Leukemia. Sampling was carried out at To: basal condition; T1: 12 hours after intravenous administration of sodium bicarbonate, before administering Mtx and T2: 3 hours after administering Mtx, the time of maximum concentration. Chiron-Diagnostic 378® equipment was used to determine pH and sodium bicarbonate. The data was interpreted using Analysis of Variance at the 5% significance level. Results: The highest values of sodium bicarbonate were observed at T2, with salivary pH levels remaining within neutrality ranges, diminishing slightly in T1. Conclusion. In this study, the dose of sodium bicarbonate considered in the administration protocol of 3 g /m² Mtx, kept sodium bicarbonate levels in saliva at normal levels and pH neutral.
Principais autores: | , , , , , |
---|---|
Formato: | Digital revista |
Idioma: | English |
Publicado em: |
Sociedad Española de Medicina Oral
2007
|
Acesso em linha: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1698-69462007000600005 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
id |
oai:scielo:S1698-69462007000600005 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1698-694620070006000052008-07-18pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemiaRojas de Morales,ThaisNavas,RitaViera,NinoskaÁlvarez,Carmen JuliaChaparro,NeiraGriman,Dariana Salivary pH salivary sodium bicarbonate methotrexate leukemia Objective: To analyze the behavior of pH and sodium bicarbonate (NAHCO3) in the saliva of patients with leukemia during the administration protocol for Methotrexate (Mtx). Materials and Methods: A controlled clinical essay was carried out on 23 patients between 4 and 18 years of age with high-risk Acute Lymphoblastic Leukemia. Sampling was carried out at To: basal condition; T1: 12 hours after intravenous administration of sodium bicarbonate, before administering Mtx and T2: 3 hours after administering Mtx, the time of maximum concentration. Chiron-Diagnostic 378® equipment was used to determine pH and sodium bicarbonate. The data was interpreted using Analysis of Variance at the 5% significance level. Results: The highest values of sodium bicarbonate were observed at T2, with salivary pH levels remaining within neutrality ranges, diminishing slightly in T1. Conclusion. In this study, the dose of sodium bicarbonate considered in the administration protocol of 3 g /m² Mtx, kept sodium bicarbonate levels in saliva at normal levels and pH neutral.Sociedad Española de Medicina OralMedicina Oral, Patología Oral y Cirugía Bucal (Internet) v.12 n.6 20072007-10-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1698-69462007000600005en |
institution |
SCIELO |
collection |
OJS |
country |
España |
countrycode |
ES |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-es |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Rojas de Morales,Thais Navas,Rita Viera,Ninoska Álvarez,Carmen Julia Chaparro,Neira Griman,Dariana |
spellingShingle |
Rojas de Morales,Thais Navas,Rita Viera,Ninoska Álvarez,Carmen Julia Chaparro,Neira Griman,Dariana pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia |
author_facet |
Rojas de Morales,Thais Navas,Rita Viera,Ninoska Álvarez,Carmen Julia Chaparro,Neira Griman,Dariana |
author_sort |
Rojas de Morales,Thais |
title |
pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia |
title_short |
pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia |
title_full |
pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia |
title_fullStr |
pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia |
title_full_unstemmed |
pH and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia |
title_sort |
ph and salivary sodium bicarbonate during the administration protocol for methotrexate in children with leukemia |
description |
Objective: To analyze the behavior of pH and sodium bicarbonate (NAHCO3) in the saliva of patients with leukemia during the administration protocol for Methotrexate (Mtx). Materials and Methods: A controlled clinical essay was carried out on 23 patients between 4 and 18 years of age with high-risk Acute Lymphoblastic Leukemia. Sampling was carried out at To: basal condition; T1: 12 hours after intravenous administration of sodium bicarbonate, before administering Mtx and T2: 3 hours after administering Mtx, the time of maximum concentration. Chiron-Diagnostic 378® equipment was used to determine pH and sodium bicarbonate. The data was interpreted using Analysis of Variance at the 5% significance level. Results: The highest values of sodium bicarbonate were observed at T2, with salivary pH levels remaining within neutrality ranges, diminishing slightly in T1. Conclusion. In this study, the dose of sodium bicarbonate considered in the administration protocol of 3 g /m² Mtx, kept sodium bicarbonate levels in saliva at normal levels and pH neutral. |
publisher |
Sociedad Española de Medicina Oral |
publishDate |
2007 |
url |
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1698-69462007000600005 |
work_keys_str_mv |
AT rojasdemoralesthais phandsalivarysodiumbicarbonateduringtheadministrationprotocolformethotrexateinchildrenwithleukemia AT navasrita phandsalivarysodiumbicarbonateduringtheadministrationprotocolformethotrexateinchildrenwithleukemia AT vieraninoska phandsalivarysodiumbicarbonateduringtheadministrationprotocolformethotrexateinchildrenwithleukemia AT alvarezcarmenjulia phandsalivarysodiumbicarbonateduringtheadministrationprotocolformethotrexateinchildrenwithleukemia AT chaparroneira phandsalivarysodiumbicarbonateduringtheadministrationprotocolformethotrexateinchildrenwithleukemia AT grimandariana phandsalivarysodiumbicarbonateduringtheadministrationprotocolformethotrexateinchildrenwithleukemia |
_version_ |
1755940918113861632 |